Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu
Trial record 76 of 119 for:    DUTASTERIDE

A Phase II Neoadjuvant Study of Enzalutamide, Abiraterone Acetate, Dutasteride and Degarelix in Men With Localized Prostate Cancer Pre-prostatectomy

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02159690
Recruitment Status : Withdrawn (loss of funding)
First Posted : June 10, 2014
Last Update Posted : January 26, 2015
Prostate Cancer Foundation Norway
Information provided by (Responsible Party):
Kenneth Pienta, MD, Johns Hopkins University

No Study Results Posted on for this Study
Study was withdrawn before participants were enrolled.
Recruitment Status : Withdrawn
Actual Primary Completion Date : January 2015
Actual Study Completion Date : January 2015